Map | A Partnership for Children's Health Search:  Advanced Search
Home General Information Country Support Board Task Forces Resources Media Center
About the Board Last Board Meeting Members Board Reports EC reports Private Access
Printer-friendly format

Quick Reference:

What is GAVI?

GAVI Alliance fact sheets


Board Documents


Press Releases

Immunization Information

Immunization Forum
Latest Issue

GAVI Update



Paris, France, 19-20 July, 2005
Summary Report

>>Back to the 16th GAVI Board Meeting
  • Presentation - Long-tem supply and procurement strategy:  Donald Strombom, Consultant
    ( PPT - 581K)
  • Presentation - Update on supplier study:  Wendy Woods, Boston Consulting Group
    ( PPT - 237K)
  • Presentation - Next steps:  David Fleming
    ( PPT - 53K)
  • Global Vaccine Supply: the Changing Role of Suppliers
    ( PDF - 36K)
  • GAVI/VF Long-term supply strategy
    ( PDF - 38K)
  • 7. Long-term supply and procurement strategy

    • In the near-term it will be important to focus on Hib and hepB-containing products; supply strategies for potential future vaccines cannot be determined until more information becomes available.
    • The procurement process will need to be underway by early 2006 so the work to develop the supply strategy should be ‘turbo-charged’.
    • Experience has shown that policies aimed at quickly reducing prices may not encourage entry of additional manufacturers and long-term sustainable supply.
    • From the increased number of Hib and hepB-containing combination vaccines currently in the pipeline, we can see that in its first phase GAVI has indeed been a ‘market shaper’.
    • Strategies must be developed such that they do not encourage production beyond reasonable demand. Careful attention must be paid to forecasting, and the supply task team must involve experts with direct experience in buying and manufacturing.


    The Board:

      Endorsed the proposal to create a small task team of GAVI partners that would begin work immediately to lead the next steps on the supply strategy for Hib and hepB combination vaccines. The Secretariat should engage a consultant to support the task team.

      Expressed concern at the slow progress in this area and insisted that the work of this team move quickly, with a progress report to the joint Executive Committee meeting in September. The final recommendations will be presented for Board approval in December.

      The recommendations of the task team will be shared with an independent expert review team.

    >>Back to the 16th GAVI Board Meeting

    Go here for presentations

    Go here for documents


    1. Report from the field: Malawi
    2. GAVI/Vaccine Fund in Phase 2—Executive Secretary Report
    3. Investment case development, review and decision-making process
    4. Bridge financing investment case
    5. New vaccines in phase 2
    6. IFFIm-Dependent Investment Cases
    7. Long-term supply and procurement strategy
    8. The International Finance Facility for Immunization
    9. Immunization services support and health system strengthening
    10. Technical support in phase 2
    11. GAVI/VF 2006-07 Work Plan Framework
    12. Yellow fever stockpile evaluation
    star_int   Contact us | Guestbook | Copyrights | Text site